CAS 63968-75-2
:4-chlor-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamid
Indapamide Related Compound A (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide)
CAS:Sulfonamides, nesoiFormel:C16H14ClN3O3SFarbe und Form:Yellow Brown PowderMolekulargewicht:363.04444INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS)
CAS:Formel:C16H14ClN3O3SReinheit:98%Farbe und Form:SolidMolekulargewicht:363.8187Indapamide EP Impurity B (Indapamide USP Related Compound A, Dehydro Indapamide)
CAS:Formel:C16H14ClN3O3SFarbe und Form:White To Off-White SolidMolekulargewicht:363.83Indapamide
CAS:Kontrolliertes ProduktFormel:C16H14ClN3O3SFarbe und Form:White To Off-WhiteMolekulargewicht:363.824-Chloro-N-(2-methyl-1H-indol-1-yl)-3-sulphamoylbenzamide
CAS:Kontrolliertes ProduktFormel:C16H14ClN3O3SFarbe und Form:White To Light BrownMolekulargewicht:363.82Dehydro Indapamide
CAS:Kontrolliertes ProduktImpurity Indapamide USP Related Compound A/ Indapamide EP Impurity B
Applications A metabolite of Indapamide (M5). A dehydrogenation pathway by cytochromes P450. Indapamide USP Related Compound A
References Tamura A., et al.: Chem. Pharm. Bull., 38, 225 (1990), Harlow, G.R., et al.: J. Biol. Chem., 272, 5396 (1997), Ozden, T., et al.: Pharm. Pharmacol. Commun., 4, 397 (1998), Gruciani, G., et al.: J. Med. Chem., 48, 6970 (2005), Sun, H., et al.: Drug. Metab. Dispos., 37, 672 (2009),Formel:C16H14ClN3O3SFarbe und Form:NeatMolekulargewicht:363.82Dehydroindapamide
CAS:Dehydroindapamide is the indole form of Indapamide that serves as a quantitative analytical standard for measuring Indapamide turnover by CYP3A4, demonstrating approximately tenfold higher metabolic turnover than Indoline and slightly enhanced CYP3A4 affinity, thereby supporting detailed studies of drug metabolism, enzyme kinetics, and pharmacokinetic profiling.Formel:C16H14ClN3O3SReinheit:99.65%Farbe und Form:White SolidMolekulargewicht:363.82Dehydro indapamide
CAS:Dehydro indapamide is a drug that belongs to the class of antihypertensive agents. It is a prodrug that is metabolized in vivo to indapamide and hydrochlorothiazide. Dehydro indapamide has been shown to be efficacious in the treatment of hypertension, and it has a pharmacokinetic profile similar to other diuretics. The clinical data for this drug are limited, but there have been no serious side effects reported with its use.
Formel:C16H14ClN3O3SReinheit:Min. 95%Molekulargewicht:363.82 g/mol











